PubMed · 14664901
The DDAH/ADMA/NOS pathway.
Abstract
An increasing number of reports in the literature indicate that endogenously produced inhibitors of nitric oxide synthase (NOS), particularly asymmetric dimethylarginine (ADMA) regulate nitric oxide generation in numerous disease states. Two dimethylarginine dimethylaminohydrolase (DDAH) enzymes metabolise ADMA. We and others have postulated that activity of DDAH is a key determinant of ADMA levels in vivo. This review summarises recent advances in the regulation and function of DDAH enzymes and its role in the regulation of nitric oxide generation.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Cam T L Tran, James M Leiper, Patrick Vallance. 2003. The DDAH/ADMA/NOS pathway.. https://doi.org/10.1016/s1567-5688(03)00032-1
Cite the original work for its findings. Save a collection to share your selection of sources.